Abstract Uromodulin (UMOD) mutations were described in patients with medullary cystic kidney disease (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD). UMOD transcription is activated by the transcription factor HNF1B. Mutations in HNF1B cause a phenotype similar to FJHN/ GCKD but also congenital anomalies of the kidney and the urinary tract (CAKUT). Moreover, we recently detected UMOD mutations in two patients with CAKUT. As HNF1B and UMOD act in the same pathway and cause similar phenotypes, we here examined whether UMOD mutations would be found in patients with CAKUT. Mutation analysis of UMOD was performed in 96 individuals with CAKUT by direct sequencing of exons 4 and 5 and by heteroduplex analysis following CEL I digestion assay of exons 3 and 6-12. Mean patient age was 11.4 years, and in 36.4% of patients, family history was positive for CAKUT. In the CEL I assay, 12 aberrant bands were detected in 103 of 960 polymerase chain reaction (PCR) products and were sequenced. Six previously known and seven new single nucleotide polymorphisms (SNPs) were detected. As no UMOD mutations were identified in these 96 patients with CAKUT, UMOD mutations do not seem to be a significant cause of CAKUT in this cohort.
Introduction
The Uromodulin (UMOD) gene encodes Tamm-Horsfall protein (THP), which is the most abundant urinary protein in humans [1] . UMOD mutations were found in a large variety of different kidney diseases: (1) medullary cystic kidney disease type 2 (MCKD2) [2] , (2) familial juvenile hyperuricemic nephropathy (FJHN) [3, 4] , and (3) glomerulocystic kidney disease (GCKD) [4] . All of these disorders are inherited in an autosomal dominant mode and represent a progressive tubulointerstitial nephropathy. Multiple groups including our own have confirmed mutations in UMOD as causing MCKD2, FJHN, and GCKD [3] [4] [5] [6] .
We analyzed the UMOD gene for mutations in a cohort of 96 patients with congenital anomalies of the kidney and the urinary tract (CAKUT) for following reasons:
1. UMOD is strongly expressed in the newborn mouse kidney and is regulated by the transcription factor Brn1 during renal development [7] . Homozygous Brn1 knockout mice die postnatally due to renal insufficiency and renal hypoplasia. 2. Interestingly, we detected in our cohort of patients with UMOD mutations two individuals, who also had associated CAKUT. One individual had right renal hypoplasia and the other had vesicoureteral reflux [8] .
No other related urinary tract malformations in patients with UMOD mutations have been published so far. 3. Gresh et al. showed that several genes responsible for cystic kidney disease (e.g. PKD1, PKD2, PKHD1, NPHP1), including UMOD, are under transcriptional control of HNF1B and form a transcriptional network [9] . A recent publication reports that 29% of all fetal bilateral hyperechogenic kidneys are caused by mutations in HNF1B [10] . Salomon et al. found HNF1B mutations in three out of 105 individuals with sporadic renal hypoplasia/dysplasia [11] . Interestingly, mutations in the HNF1B gene can also result in a phenotype similar to MCKD2, including renal cysts and renal failure (RCAD syndrome) [12] . Besides renal cysts and maturity-onset diabetes of the young type 5 (MODY5), patients with mutations in HNF1B also have various renal abnormalities, including renal agenesis, renal dysplasia [12] , and hypoplastic GCKD [13] . Moreover, a phenotype similar to FJHN with severe hyperuricemia due to HNF1B mutations [14] , which is usually caused by UMOD mutations, was published.
Taking the phenotypical similarities between patients with mutations in UMOD and HNF1B into account and recognizing that Brn1 and HNF1B are transcription factors, which regulate UMOD and result in a CAKUT phenotype when mutated, we examined whether UMOD mutations are a frequent cause of CAKUT in a world-wide cohort of 96 CAKUT individuals. No mutations were detected. We conclude that UMOD mutations are not a frequent cause of CAKUT in this cohort.
Methods

Patients
We ascertained 96 individuals with urinary tract malformations from 20 pediatric nephrology units in five European countries (Germany, Macedonia, United Kingdom, Hungary, Serbia) and the United States. Patients were included in the study if a diagnosis compatible with congenital abnormality of the kidney or the genital tract was established by a pediatric nephrologist. Presenting symptoms encompassed urinary tract infection, prenatal ultrasound, workup for abdominal pain, abdominal masses, hypertension, and chronic renal failure. Ultrasound, voiding cystourethrography (VCUG), intravenous pyelogram, or scintigraphy was performed to establish the correct diagnosis. Further clinical characteristics of the 96 individuals are shown in Table 1 . The family history was interpreted as positive if one or more closely related individuals were also identified with a CAKUT phenotype. Glomerular filtration rate (GFR) was calculated using the Schwartz formula. The study was approved by the institutional review board of the University of Michigan Medical School. All participating family members provided informed consent.
Mutational analysis of the UMOD gene
We used standard methods to isolate genomic deoxyribonucleic acid (DNA) from peripheral blood samples accord- ing to the manufacturer's instructions (Puregene™, Gentra Systems). Mutational analysis of UMOD exons 4 and 5 was performed by exon polymerase chain reaction (PCR) and direct sequencing, as most mutations to date have been identified in these 2 exons [2] [3] [4] [5] [6] 8] . Primer sequences were used as described by Wolf et al. [5] . PCR products were purified, sequenced, and analyzed as previously described [15] .
CEL I endonuclease preparation Exons 1 and 2 do not encode translated parts of UMOD; they contain only 5′ untranslated regions and were therefore not included in the analysis. Exons 3 and 6-12 were examined by exon PCR, CEL I endonuclease digest, and heteroduplex analysis, with consecutive sequencing of products yielding aberrant bands. Preparation of crude extract containing 30 kDa single-strand-specific endonuclease CEL I was purified from celery, as described [16, 17] .
Heteroduplex formation and CEL I treatment
The CEL I endonuclease enzyme recognizes single base mismatches present in heteroduplex DNA and cleaves both strands. Heteroduplex DNA was obtained by heat denaturing 2 μl of an exon-PCR-amplified patient DNA sample. DNA fragments were denatured at 95°C for 10 min followed by gradual cooling. The reaction mixture was incubated at 45°C for 5 min, put on ice, and stopped by mixing with glycerol-containing (30%) loading buffer supplemented with ethylenediaminetetraacetate (EDTA) (final concentration 250 mM), followed by a 1.5% agarose gel electrophoretic separation of the digested fragments for 1 h at 150 V. Samples showing aberrant bands were purified and directly sequenced.
Results
We analyzed the genomic DNA of 96 patients from 96 different families with CAKUT from Central Europe, Eastern Europe, and the United States for UMOD sequence variations. Mean age at examination was 11.4 years (range 3 months to 44 years), the cohort consisted of 60% males, and estimated mean GFR at examination was 89.6 ml/min per 1.73 m 2 (range 13-167 ml/min per 1.73 m 2 ) ( Table 1 ). In 36.4% of all patients, a positive family history was found. Clinical data on identified CAKUT phenotypes is shown in Table 1 .
Exons 3 and 6-12 were analyzed by CEL I heteroduplex analysis. Exons 4 and 5, in which 95% of all UMOD mutations have been found so far, were analyzed by direct sequencing to reduce the possibility of missing a mutation by CEL I heteroduplex analysis. The CEL I assay resulted in 12 different aberrant band patterns in 103 samples out of a total of 960 PCR products. These 103 samples were subsequently sequenced (Table 2) .
Of the 12 different aberrant band patterns of the CEL I heteroduplex analysis, three aberrant band patterns represented three known single nucleotide polymorphisms (SNPs): rs36060036, rs4506906, and rs55772253 [18] were identified in exons 3, 6 and 8, respectively. Only for SNP rs4506906 in exon 6 was an allele frequency given. Published heterozygosity for rs4506906 is 0.516 in a European population. We identified a heterozygosity of 0.447 in our cohort ( Table 2) .
Of the 12 different aberrant band patterns of the CEL I heteroduplex analysis, seven aberrant band patterns represented novel SNPs: in 23 patients, new sequence variants were found in exons 3, 6, 7, 8, 9, and 12, respectively (Table 2 ). Of the seven novel SNPs, four did not affect the encoding region of UMOD: three of them were located in the 5′ untranslated region (UTR) (two in exon 3), and one was located in the the 3′ UTR (one in exon 12) and had no effect on the encoded amino acid sequence (see Table 2 ).
Of the seven novel SNPs, three are located in the encoding region of UMOD. Two of these SNPs in exons 7 and 8 were found to result in the same amino acid (P428P and Y486Y, respectively). One of the SNPs located in the encoding region resulted in an altered amino acid. This novel SNP was c.1124G>A in exon 6, which resulted in the amino acid glutamine instead of arginine (R375Q). Both parents of this patient had CAKUT, and thus segregation studies were not informative. However, the evolutionary conservation of glutamine (Q) at this position was found to be poor, as there is a glutamine residue at this position in rabbit, armadillo, and opossum. Because of the poor evolutionary conservation, we concluded that this sequence variant represents another rare SNP. Two of the 12 aberrant band patterns in exons 7 and 9 showed no sequence variation and were interpreted as artifacts.
Mutation analysis of exons 4 and 5 by direct sequencing detected no mutations but included analysis of three known SNPs (two in exon 4 and one in exon 5). For two of them, no population frequency was given. For SNP rs13335818 in exon 4, the population frequency matched very well the expected numbers given by the National Center for Biotechnology Information (NCBI) SNP database ( Table 2 ). In conclusion, no mutation accountable for the CAKUT phenotype was detected.
Discussion
Developmental abnormalities of the kidney are diverse and include renal agenesis, multiple ureters, and renal hypopla-sia and dysplasia, each of which corresponds to defects at a particular stage of development [19] . Multiple genes, including ROBO2, EYA1, SIX1, SIX2, SIX5, BMP4, and PAX2, have been identified to be responsible for CAKUT [20] [21] [22] [23] [24] [25] . In addition, identical mutations in the same gene were found to result in diverse phenotypes due to the stochastic nature of developmental defects [26] . Mutations in HNF1B can either cause an FJHN/GCKD-like pheno- [8] . We assembled a CAKUT patient cohort similar to the one used by Weber et al. [21] , taking the wide variety of CAKUT and the stochastic nature of developmental defects into account. Several studies have shown that identical mutations can result in a wide range of CAKUT phenotypes. However, perhaps we should have examined only patients with VUR and hypoplastic kidneys, as these were the CAKUT symptoms of the two UMOD patients, in order to obtain a higher yield of mutations.
In this study, we looked only for dominant sequence variations, as UMOD mutations are inherited in an autosomal dominant manner. To obtain heteroduplexes that may be cut by CEL I, an equal concentration of a wild-type and an altered allele are combined and form a heteroduplex after denaturation and gradual cooling. As we were looking for heterozygous variations, we analyzed only patient DNA and did not mix the DNA sample with another heterozygous DNA sample, which would have been necessary to detect homozygous SNP alterations. This experimental limitation does not allow us to give the frequency for homozygous SNPs (Table 2) .
Altogether we examined 96 patients with CAKUT for sequence alteration in the UMOD gene and could not identify a mutation responsible for the CAKUT phenotype. We cannot rule out the possibility that these genes would represent less than 1% of observed cases with CAKUT. It is also possible that there could be mutations in known or unknown regulatory elements of UMOD.
